Mark S. Florence

SenGenix, Inc. develops point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors. The firm’s FRS-based strips are used to test various types of clinical analytes, including electrolytes, metabolites, drugs, proteins and cells. The company was founded in 2012 and is headquartered in Durham, NC.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ.

Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY.